According to CNN and WSYR-TV, the company said in a statement Tuesday that it "discovered inconsistencies in how we weigh ingredients for Excedrin Extra Strength Caplets and Geltabs, and Excedrin Migraine Caplets and Geltabs." The inconsistencies should not affect customer safety, the statement read.
The company added that it is “working hard to resolve the issue as quickly as possible” but could not say when it would start producing the items again, the outlets reported.
“Other Excedrin products are available along with other pain-relieving drugs, but dosages may differ,” the statement said.
WSYR reported that some drugstores had a shortage of Excedrin products as a result.
In Other News
1
The Latest | World leaders call on Iran and Israel to avoid allowing...
2
Kansas has a new anti-DEI law, but the governor has vetoed bills on...
3
Live video of man who set himself on fire outside court proves...
4
Tennessee Volkswagen workers vote on union membership in test of UAW's...
5
Idaho group says it is exploring a ballot initiative for abortion...
About the Author